Contracting giant Catalent says its pre-filled syringe facility in Brussels, Belgium has received Food and Drug Administration approval for the manufacture of products for the US market.
European technical services and industrial engineering specialist
Imtech says it has received orders worth around €40m ($64m) from
the Belgian operations of firms such as Janssen Pharmaceutica,
GlaxoSmithKline (GSK) and Schering Plough.